Kestra Medical Technologies, Ltd. Common Stock KMTS Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $83.72M+69.0% | $74.26M+79.4% | $66.4M+97.4% | $59.82M+115% | $49.54M— | ||
| $42.91M+30.5% | $39.8M+27.6% | $37.54M+28.7% | $35.61M+29.7% | $32.87M— | ||
| $40.81M+145% | $34.46M+237% | $28.86M+545% | $24.21M+6,588% | $16.67M— | ||
| 48.8%+15.1pp | 46.4%+21.7pp | 43.5%+30.2pp | 40.5%+39.2pp | 33.6%— | ||
| $19.24M+36.1% | $17.62M+20.2% | $16.25M+8.2% | $15.65M+1.0% | $14.14M— | ||
| $165.19M+102% | $146.28M+93.4% | $129.44M+80.6% | $114.94M+64.3% | $81.96M— | ||
| $184.42M+91.9% | $163.9M+81.5% | $145.69M+68.0% | $130.59M+52.9% | $96.1M— | ||
| -$143.61M-80.8% | -$129.45M-61.6% | -$116.83M-42.1% | -$106.38M-25.1% | -$79.43M— | ||
| -171.5%-11.2pp | -174.3%+19.2pp | -175.9%+68.5pp | -177.8%+128pp | -160.4%— | ||
| $7.46M-0.9% | $7.36M+0.7% | $7.77M+18.7% | $7.73M+24.1% | $7.53M— | ||
| -$395K+48.9% | -$739K+50.4% | $112K+105% | -$2.77M+1.3% | -$773.75K— | ||
| -$143.68M-66.7% | -$131.29M-49.2% | -$119.16M-31.1% | -$113.68M-20.8% | -$86.19M— | ||
| $204K+423% | $187K+593% | $161K+544% | $135K+463% | $39K— | ||
| -$144.83M-69.8% | -$132.17M-51.4% | -$119.76M-32.4% | -$113.81M-20.9% | -$85.29M— | ||
| -173%-0.8pp | -178%+32.9pp | -180.3%+88.6pp | -190.3%+148pp | -172.2%— | ||
| -$3.32+31.2% | -$3.96+18.3% | -$4.51+8.4% | -$5.13-1.2% | -$4.83— | ||
| -$135.39M-92.3% | -$121.32M-73.1% | -$109.2M-53.4% | -$98.41M-33.9% | -$70.41M— | ||
| -161.7%-19.6pp | -163.4%+5.9pp | -164.5%+47.1pp | -164.5%+99.7pp | -142.1%— | ||
| -$143.61M-80.8% | -$129.45M-61.6% | -$116.83M-42.1% | -$106.38M-25.1% | -$79.43M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Kestra Medical Technologies, Ltd. Common Stock's revenue?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated $83.7M in revenue over the trailing twelve months, up 69.0% year over year.
- Is Kestra Medical Technologies, Ltd. Common Stock profitable?
- Kestra Medical Technologies, Ltd. Common Stock is not currently profitable: it reported a net loss of $144.8M over the trailing twelve months, a -173.0% net margin.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Gross margin is 48.8% and operating margin is -171.5%, with a -173.0% net margin.
- What is Kestra Medical Technologies, Ltd. Common Stock's earnings per share?
- Kestra Medical Technologies, Ltd. Common Stock's diluted EPS over the trailing twelve months is $-3.32.
- Where does Kestra Medical Technologies, Ltd. Common Stock's income statement data come from?
- Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
